Acta Neuropathologica Communications (Feb 2022)

A postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics

  • Gaël Nicolas,
  • Myriam Sévigny,
  • François Lecoquierre,
  • Florent Marguet,
  • Andréanne Deschênes,
  • Maria Carment del Pelaez,
  • Sébastien Feuillette,
  • Anaïs Audebrand,
  • Magalie Lecourtois,
  • Stéphane Rousseau,
  • Anne-Claire Richard,
  • Kévin Cassinari,
  • Vincent Deramecourt,
  • Charles Duyckaerts,
  • Anne Boland,
  • Jean-François Deleuze,
  • Vincent Meyer,
  • Jordi Clarimon Echavarria,
  • Ellen Gelpi,
  • Haruhiko Akiyama,
  • Masato Hasegawa,
  • Ito Kawakami,
  • Tsz H. Wong,
  • Jeroen G. J. Van Rooij,
  • John C. Van Swieten,
  • Dominique Campion,
  • Paul A. Dutchak,
  • David Wallon,
  • Flavie Lavoie-Cardinal,
  • Annie Laquerrière,
  • Anne Rovelet-Lecrux,
  • Chantelle F. Sephton

DOI
https://doi.org/10.1186/s40478-022-01314-x
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Frontotemporal dementia (FTD) is a heterogeneous clinical disorder characterized by progressive abnormalities in behavior, executive functions, personality, language and/or motricity. A neuropathological subtype of FTD, frontotemporal lobar degeneration (FTLD)-FET, is characterized by protein aggregates consisting of the RNA-binding protein fused in sarcoma (FUS). The cause of FTLD-FET is not well understood and there is a lack of genetic evidence to aid in the investigation of mechanisms of the disease. The goal of this study was to identify genetic variants contributing to FTLD-FET and to investigate their effects on FUS pathology. We performed whole-exome sequencing on a 50-year-old FTLD patient with ubiquitin and FUS-positive neuronal inclusions and unaffected parents, and identified a de novo postzygotic nonsense variant in the NCDN gene encoding Neurochondrin (NCDN), NM_014284.3:c.1206G > A, p.(Trp402*). The variant was associated with a ~ 31% reduction in full-length protein levels in the patient’s brain, suggesting that this mutation leads to NCDN haploinsufficiency. We examined the effects of NCDN haploinsufficiency on FUS and found that depleting primary cortical neurons of NCDN causes a reduction in the total number of FUS-positive cytoplasmic granules. Moreover, we found that these granules were significantly larger and more highly enriched with FUS. We then examined the effects of a loss of FUS function on NCDN in neurons and found that depleting cells of FUS leads to a decrease in NCDN protein and mRNA levels. Our study identifies the NCDN protein as a likely contributor of FTLD-FET pathophysiology. Moreover, we provide evidence for a negative feedback loop of toxicity between NCDN and FUS, where loss of NCDN alters FUS cytoplasmic dynamics, which in turn has an impact on NCDN expression.

Keywords